2-Ethyl-3-methylpyrazine

We are 2-Ethyl-3-methylpyrazine CAS:15707-23-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Ethyl-3-methylpyrazine
CAS.NO:15707-23-0
Synonyms:2-Ethyl-3-methylpyrazine
3-METHYL-2-ETHYLPYRAZINE
2-Ethyl-3-Methylpyra
3-Ethyl-2-methylpirazine
1-Ethyl-2-Methylpyrazin
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 173.5±35.0 °C at 760 mmHg
Molecular Formula C7H10N2
Molecular Weight 122.168
Flash Point 57.2±0.0 °C
 
Specification:
Appearance:Colorless liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate

2-Ethyl-3-methylpyrazine


Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.1-isothiocyanato-3,5-bis(trifluoromethyl)benzene Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.4-Nitrophenyl chloroformate CAS:7693-46-1 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.2,4-Dichloro-6-[1,1':3',1''-terphenyl]-5'-yl-1,3,5-Triazine CAS:1616232-09-7 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.

Related Products
Product Name
3,5-Diiodosalicylic acid View Details
1,2-Cyclohexanedicarboximide View Details
5-Chloro-2-fluorotoluene View Details
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate manufacturer 2,4-Bis(trifluoromethyl)aniline manufacturer 2-Chloro-3-amino-4-methyl pyridine manufacturer 3-Chloropropyl acetate manufacturer 4-Methoxybenzoyl chloride manufacturer